Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Ignacio Duran, MD, PhD, of the Hospital Universitario Virgen del Rocío, Seville, Spain, explains the fast pace of research currently in the oncology field; specifically, he mentions combinations of immunotherapy and antiangiogenics for the treatment of kidney cancer. This video was filmed at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.